allinaire therapeutics allinaire therapeutics  breakthrough medicinelearn more aiming to find a cure for pulmonary diseases at allinaire therapeutics we have identified a novel target to halt the progression of chronic obstructive pulmonary disease copd and other pulmonary diseases   technologylearn more about our breakthrough discoveries in lung disease learn more → teammeet our drug development expertslearn more → allinaire therapeutics llc company profile  bloomberg feedback allinaire therapeutics llc private company company profile sector health care industry biotech  pharma subindustry specialty pharma allinaire therapeutics llc operates as a pharmaceutical company the company develops novel therapeutics for chronic obstructive pulmonary disease and other pulmonary diseases allinaire therapeutics serves customers in the united states corporate information address  chagrin blvd suite  cleveland oh  united states phone  fax  web url wwwallinairecom from the web sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version allinaire therapeutics llc  company profile  biocentury publications archives bciq conferences version  free trial  subscribe sign in english   한국어 biocentury menu home  publications  publications home  biocentury bc innovations bc extra bc week in review current issues archives  archives home  basic search advanced search back issues bciq  bciq home  overview pipeline analyst financial analyst company analyst deal analyst conferences  conferences home  newsmakers bio€quity europe future leaders china healthcare summit other industry events elearning  elearning home  videos white papers follow us bciq  company profile bciq overview      settings      support biocentury print this       allinaire therapeutics llc print preview export bookmark share with colleague general information  location cleveland ohio  region midwest  country us  business category pulmonary  year founded   website httpwwwallinairecom  lead product status preclinical  archive items are loading  financial information  financing summary  financing details  earnings summary  stocks annual chart  pipeline information  pipeline summary  pipeline details  deals information  deals summary  deals details about biocentury company overview management editorial  research contact contact us advertising  sponsorship career opportunities support forgot password customer service reprints faqs products  solutions products overview publications archives bciq conferences elearning rss feeds legal user agreement terms of use privacy policy your california privacy rights use of images follow us what is biocentury biocentury employs a fully integrated multimedia platform — including publications video online data solutions and conferences — to provide its audience with authoritative and uptodate intelligence about corporate strategy partnering emerging technology clinical data public policy and the financial markets sign in free trial   biocentury inc all rights reserved    terms  conditions  privacy policy set email alert dummy overview — allinaire therapeutics allinaire therapeutics novel therapeutics allinaire therapeutics is developing novel therapeutics for pulmonary diseases allinaire therapeutics aims to develop novel therapeutics for chronic obstructive pulmonary disease copd and other pulmonary diseases the technology is based on the discovery by scientific founders irina petrache md and matthias clauss phd of a novel therapeutic target that plays a central role in the development and progression of lung diseasedrs petrache and clauss have demonstrated that a therapeutic antibody against this target has a strong potential as a disease  modifying treatment to slow the progression of copd this approach will dramatically change the treatment landscape for copd — dr irina petrache scientific founder copd is a very common disease that represents a large unmet global need by  it is estimated that copd will the third leading cause of death this disease is characterized by inflammation and progressive destruction of lung tissue leading to difficulty in breathing allinaire therapeutics aims to address this unmet medical need and transform the treatment of lung diseasesallinaire therapeutics llc has a standard overhead rate of  allinaire therapeutics may alter this policy at any time   scrip in order to deliver a personalized responsive service and to improve the site we remember and store information about how you use it this is done using simple text files called cookies which sit on your computer by continuing to use this site and access its features you are consenting to our use of cookies to find out more about the way informa uses cookies please go to our cookie policy page scrip is part of the business intelligence division of informa plc informa plc about us investor relations talent this site is operated by a business or businesses owned by informa plc and all copyright resides with them informa plc’s registered office is  howick place london swp wg registered in england and wales number  informa toggle menu menu other publications in vivo  medtech insight  pink sheet  rose sheet  register sign in this copy is for your personal noncommercial use for highquality copies or electronic reprints for distribution to colleagues or customers please call      printed by usernamepublicrestriction already registered sign in to continue reading your login andor password information does not match our records please try again forgot your password remember me sign in thanks weve sent a link to reset your password forgot your password   enter the email address associated with your account and an email will be sent to you to reset your password please enter a valid email address unfortunately weve not been able to process this request submit need help please call uk support at      us support at     or onlineaccessinformacom new to scrip request a free trial today free trial register for our free email digests your username does not meet the requirements an account with that username already exists unfortunately weve not been able to process your registration please contact support register toggle menu menu home commercial companies deals strategy market access market intelligence appointments research  development clinical trials approvals therapy areas pipeline watch policy  regulation hot topics us election  pricing debate brexit regional coverage meet the team scrip awards scrip  scrip asia  ask the analyst pdf library rss feeds free trial request subscribe advertise usernamepublicrestriction already registered sign in to continue reading your login andor password information does not match our records please try again forgot your password remember me sign in thanks weve sent a link to reset your password forgot your password   enter the email address associated with your account and an email will be sent to you to reset your password please enter a valid email address unfortunately weve not been able to process this request submit need help please call uk support at      us support at     or onlineaccessinformacom new to scrip request a free trial today free trial register for our free email digests your username does not meet the requirements an account with that username already exists unfortunately weve not been able to process your registration please contact support register email share allinaire therapeutics llc wwwallinairecom latest from syncrx ltd bookmark  mar  volcano learning to thrive in a declining pci market long used to a growing market driven by favorable demographics cardiovascular companies are facing a declining pci market in the us and europe at least and are forced to shift their strategies to adapt volcano for one is articulating a new way to approach this declining market medical device strategy see all company information industry biotechnology large molecule antibodies pharmaceuticals therapeutic areas respiratory pulmonary aliases ownership private headquarters worldwide north america usa company type startup parent  subsidiaries allinaire therapeutics llc senior management contact info allinaire therapeutics llc  chagrin blvd ste  cleveland oh  usa advertisement advertisement you must sign in to use this functionality your login andor password information does not match our records please try again forgot your password remember me sign in thanks weve sent a link to reset your password forgot your password   enter the email address associated with your account and an email will be sent to you to reset your password please enter a valid email address unfortunately weve not been able to process this request submit need help please call uk support at      us support at     or onlineaccessinformacom authenticationsigninheadsigninheader your login andor password information does not match our records please try again forgot your password remember me sign in thanks weve sent a link to reset your password forgot your password   enter the email address associated with your account and an email will be sent to you to reset your password please enter a valid email address unfortunately weve not been able to process this request submit need help please call uk support at      us support at     or onlineaccessinformacom usernamepublicrestriction register your username does not meet the requirements sorry  this email domain is not allowed sorry  public email accounts are not allowed please provide a work email address an account with that username already exists unfortunately weve not been able to process your registration please contact support register allinaire therapeutics llc email company all set this article has been sent to myemailaddress all fields are required for multiple recipients separate email addresses with a semicolon please make sure all fields are completed please enter a valid email address please make sure you have filled out all fields please make sure you have filled out all fields subject allinaire therapeutics llc add a personalized message to your email cancel send dcdemailpopoutnotice × this copy is for your personal noncommercial use for highquality copies or electronic reprints for distribution to colleagues or customers please call      printed by bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version life sciences startup receives significant funding for developing novel therapeutics for life sciences startup receives significant funding for developing novel therapeutics for respiratory diseases biocrossroads indiana seed fund ii biomotiv and ius innovate indiana lead investment in indiana university school of medicine technology news provided by biocrossroads jan    et share this article indianapolis jan   prnewswire  each year more than  million people in the us suffer from chronic obstructive pulmonary disorder copd a life threatening disease that interferes with normal breathing although  percent of people who die from copd are former smokers approximately  percent have a genetic disorder alpha antitrypsin or aat deficiency to date there is no cure for either disease only symptomatic relief methods are available dr matthias clauss scientific founder of allinaire and associate research professor of cellular  integrative physiology indiana center for vascular biology  medicine indiana university school of medicine and dr irina petrache scientific founder of allinaire and chief division of pulmonology critical care and sleep medicine national jewish health discovered that symptoms of copd and aat deficiency can be mitigated by reducing the activity of certain secreted proteins their discoveries led to the formation of allinaire therapeutics llc a life sciences startup company focusing on novel therapeutics for pulmonary diseases allinaire recently received new investments from biocrossroads indiana seed fund ii biomotiv a biomedical accelerator affiliated with the harrington project for discovery  development and indiana universitys innovate indiana fund to advance the development of therapeutics for the treatment of aat deficiency copd and other respiratory disorders including acute lung injury  in addition the company has received grant support from the national institutes of health small business innovation  research program    allinaire has great promise – an outstanding research and development team the support of one of the premier accelerator programs in the us novel science and now funding to move their innovation forward said david l johnson president and ceo biocrossroads dr petrache is a harrington scholarinnovator whose research was identified and supported by the harrington discovery institute at university hospitals in cleveland  harrington scholarinnovators receive mentorship resource connections and business support through this program allinaire therapeutics technology demonstrates great potential to become a diseasemodifying approach to copd and emphysema as class a investors innovate indiana looks forward to working closely with the allinaire therapeutics team to ensure the continued success of the technology and the company said ken green md managing director of the innovate indiana fund we are pleased to partner with biocrossroads and innovate indiana to support the advancement of these discoveries from indiana university researchers said baiju r shah ceo biomotiv  for information more about allinaire visit httpwwwallinairecom about biocrossroads biocrossroads wwwbiocrossroadscom is indianas initiative to grow advance and invest in the life sciences a publicprivate collaboration that supports the regions existing research and corporate strengths while enabling new business startups and development  biocrossroads provides capital and support to life sciences businesses launches new life sciences enterprises agrinovus indiana indiana biosciences research institute indiana health information exchange biocrossroadslinx orthoworx and datalys center expands collaboration and partnerships among indianas life science institutions promotes science education and markets indianas life sciences industry about biomotiv biomotiv is the missiondriven accelerator associated with the harrington project for discovery  development a  million initiative for advancing medicine centered at university hospitals in cleveland the focus is to accelerate breakthrough discoveries from research institutions into therapeutics for patients through an innovative model that efficiently aligns capital and collaborations the company leverages an experienced team and advisory board to select fund and actively manage and advance a portfolio of drug development programs learn more at wwwbiomotivcom about innovate indiana the innovate indiana fund is a seedstage venture fund affiliated with indiana university that partners with companies who have a meaningful iu connection to provide funding guidance and a worldclass network to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleaseslifesciencesstartupreceivessignificantfundingfordevelopingnoveltherapeuticsforrespiratorydiseaseshtml source biocrossroads related links httpwwwbiocrossroadscom feb    et preview indianas life sciences industry economic impact climbs to  billion jun    et preview indianas life sciences industry maintains its top  employment ranking continues leadership in pharmaceuticals medical device and agricultural biosciences my news release contains wide tables view fullscreen also from this source feb    et indianas life sciences industry economic impact climbs to  explore more news releases in similar topics health care  hospitals medical equipment medical pharmaceuticals clinical trials  medical discoveries you just read life sciences startup receives significant funding for developing novel therapeutics for respiratory diseases news provided by biocrossroads jan    et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search   allinaire therapeutics llc private company information  bloomberg july    pm et biotechnology company overview of allinaire therapeutics llc snapshot people company overview allinaire therapeutics llc develops therapeutics for chronic obstructive pulmonary disease and other pulmonary diseases the company was incorporated in  and is based in cleveland ohio  chagrin boulevardsuite cleveland oh united statesfounded in  wwwallinairecom key executives for allinaire therapeutics llc mr wade lange founder and senior adviser dr irina petrache md scientific founder dr matthias clauss phd scientific founder dr douglas hay phd project director dr elizabeth berezovsky phd project manager compensation as of fiscal year  similar private companies by industry company name region n labs inc united states andme inc united states c tech corporation inc united states v biosciences inc united states bar biologics inc united states recent private companies transactions typedate target private placement december    request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact allinaire therapeutics llc please visit wwwallinairecom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close